EffRx Pharmaceuticals SA Revenue and Competitors

Freienbach,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • EffRx Pharmaceuticals SA's estimated annual revenue is currently $3M per year.(i)
  • EffRx Pharmaceuticals SA's estimated revenue per employee is $201,000

Employee Data

  • EffRx Pharmaceuticals SA has 15 Employees.(i)
  • EffRx Pharmaceuticals SA grew their employee count by -6% last year.

EffRx Pharmaceuticals SA's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head AccountingReveal Email/Phone
3
Head Regulatory Affairs - Senior DirectorReveal Email/Phone
4
Director Technical Operations and Qualified PersonReveal Email/Phone
5
Supply Chain ManagerReveal Email/Phone
6
Communications ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is EffRx Pharmaceuticals SA?

EffRx Pharmaceuticals is a commercial-stage pharmaceutical company focused on the late-stage development and commercialization of prescription medications for niche and orphan indications. The business model is centered around providing superior clinical and commercial value propositions for physicians, payers and patients. EffRx pro-actively seeks in-licensing opportunities for Europe in niche therapeutic areas, with a primary interest for rare diseases, where EffRx has received an orphan drug designation (ODD) from FDA for a pipeline asset.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$3M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EffRx Pharmaceuticals SA News

2022-04-17 - EffRx Pharmaceuticals Signs Exclusive License Agreement With Diurnal for the Registration and Commercialization of Efmody® in Switzerland

FREIENBACH, Switzerland, April 26, 2022--(BUSINESS WIRE)--EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and...

2022-04-17 - Other news to note for April 26, 2022

Adge Pharmaceuticals Inc., of Mountain View, Calif., signed a license ... signed with Effrx Pharmaceuticals SA, of Freienbach, Switzerland.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M3776%N/A
#2
N/A4132%N/A
#3
$5.2M46-8%N/A
#4
$11.3M6036%N/A
#5
$7.6M7627%N/A